Symbicort approved for Chronic Obstructive Pulmonary Disease treatments

Share this content:
Symbicort approved for Chronic Obstructive Pulmonary Disease treatments
Symbicort approved for Chronic Obstructive Pulmonary Disease treatments

The Food and Drug Administration has approved Symbicort for residents suffering from Chronic Obstructive Pulmonary Disease COPD). The medication is intended for twice daily use. In two clinical trials, the medication helped patients breathe easier, researchers said.

http://www.symbicort.com/